Literature DB >> 9691867

Effect of xenon on central nervous system electrical activity during sevoflurane anaesthesia in cats: comparison with nitrous oxide.

J Utsumi1, T Adachi, J Kurata, Y Miyazaki, M Shibata, M Murakawa, T Arai, K Mori.   

Abstract

We have compared the effects of xenon and nitrous oxide on central nervous system (CNS) electrical activity during sevoflurane anaesthesia in cats by recording the electroencephalogram (EEG), multi-unit activity of the midbrain reticular formation (R-MUA) and somatosensory evoked potentials (SEP). Basal anaesthesia with 2% and 5% sevoflurane was used. With 2% sevoflurane, 70% xenon initially produced rhythmic slow waves which were followed by bursts of high-amplitude sharp waves interrupted by low amplitude slow waves on the EEG. Xenon induced an initial increase, followed by a decrease in R-MUA. Nitrous oxide 70% decreased the amplitude of the EEG activity which was associated with an increase in R-MUA. Xenon suppressed the amplitude of both the initial positive and negative deflections of the SEP to a greater extent than nitrous oxide. With 5% sevoflurane anaesthesia, both anaesthetics increased the frequency of spikes on the EEG and facilitated R-MUA. These findings indicate that xenon has a stimulatory action on CNS background activity and a suppressive action on CNS reactive capability which is more potent than that of nitrous oxide.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9691867     DOI: 10.1093/bja/80.5.628

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  2 in total

1.  Isoflurane anaesthetic depth in goats monitored using the bispectral index of the electroencephalogram.

Authors:  J F Antognini; X W Wang; E Carstens
Journal:  Vet Res Commun       Date:  2000-09       Impact factor: 2.459

2.  Variable effects of nitrous oxide at multiple levels of the central nervous system in goats.

Authors:  J F Antognini; X G Chen; M Sudo; S Sudo; E Carstens
Journal:  Vet Res Commun       Date:  2001-10       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.